This state-of-the-science reference and text has given thousands of practitioners and students a strong foundation in understanding and treating addictive disorders. Leading experts address the neurobiology of addictions and review best practices in assessment and diagnosis. Specific substances of abuse are examined in detail, with attention to real-world clinical considerations. Issues in working with particular populations--including polysubstance abusers, culturally diverse patients, older adults, chronic pain sufferers, and others--are explored. Chapters summarize the theoretical and empirical underpinnings of widely used psychosocial and pharmacological treatments and clearly describe clinical techniques.

New to This Edition
*Incorporates a decade's worth of major advances in research and clinical practice.
*Updated for DSM-5.
*Many new authors; extensively revised with the latest information on specific biological mechanisms, substances, populations, and treatments.
*Chapter on motivational interviewing.

Avram H. Mack, MD, is Professor of Clinical Psychiatry at Georgetown University School of Medicine and a psychiatrist at Georgetown University Hospital. He is the director of medical student education in Georgetown’s Department of Psychiatry and leads several multidisciplinary patient safety initiatives. Dr. Mack's interests include patient safety, substance use disorders, and forensic psychiatry. He is board certified in General Psychiatry, Child and Adolescent Psychiatry, Forensic Psychiatry, and Addiction Medicine. A past president of the Washington Psychiatric Society, he served on the board of  the American Psychiatric Association and on the Impaired Physicians Committee of the Medical Society of the District of Columbia. He presents, publishes, and testifies extensively regarding substance abuse.

Kathleen T. Brady, MD, PhD, a board-certified psychiatrist, is Distinguished University Professor and Associate Provost for Clinical and Translational Science at the Medical University of South Carolina. Her interests include drug and alcohol abuse/addiction and comorbid conditions. Dr. Brady leads numerous research projects and has served as president of the American Academy of Addiction Psychiatry, a member of the Scientific Advisory Council of the National Institute of Drug Abuse, and a board member of the College on Problems of Drug Dependence. She has authored over 300 publications; presented at conferences, grand rounds, and symposia; and received numerous awards.

Sheldon I. Miller, MD, until his death in 2011, was Emeritus Professor of Psychiatry and former Chairman of the Department of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine. Recognized as a national leader in addiction psychiatry, he was the author of more than 100 publications. He was Editor-in-Chief of the American Journal on Addictions and was a founder of the American Academy of Addiction Psychiatry. Dr. Miller served on the Board of Directors of the Accreditation Council for Graduate Medical Education and the American Board of Emergency Medicine. He was a Distinguished Fellow of the American Psychiatric Association and a member of the Group for the Advancement of Psychiatry.

Richard J. Frances, MD, maintains a private practice in New York, and was instrumental in the recognition of addiction psychiatry as a medical subspecialty. Board certified in Psychiatry and Addiction Psychiatry, he was a founder and the first president of the American Academy of Addiction Psychiatry. He has held leadership positions at New York Hospital--Cornell Medical Center and was president and medical director of Silver Hill Hospital. Dr. Frances is Clinical Professor of Psychiatry at New York University School of Medicine and Adjunct Professor at Rutgers New Jersey Medical School, and was director of education at the University of Medicine and Dentistry of New Jersey (now part of the Rutgers School of Biomedical and Health Sciences). He has a special interest in addiction, with a focus on impaired professionals.

I. Foundations of Addiction
1. The Neurobiology of Substance Dependence: Implications for Treatment, Thomas R. Kosten & Colin N. Haile
2. Historical and Social Context of Psychoactive Substance Disorders, Joseph Westermeyer
II. Assessment of Addiction
3. Diagnostic Assessment in Substance Abusers, Deborah Hasin & Bari Kilcoyne
4. Laboratory Testing for Substances of Abuse, D. Andrew Baron & David A. Baron
III. Substances of Abuse
5. Alcohol, Ed Nace
6. Nicotine Dependence, David Kalman, Amy Harrington, Joseph DiFranza, Lori Pbert, & Douglas Ziedonis
7. Opiate Misuse and Dependence, Sudie E. Back, Jenna L. McCauley, Kelly S. Barth, & Kathleen T. Brady
8. Cannabis, Alicia R. Murray & Frances R. Levin
9. Hallucinogens and Inhalants, Stephen Ross & Avram H. Mack
10. Caffeine, Laura M. Juliano & Greta Bielacyzc Raglan
11. Stimulants, Richard Rawson, Larissa Mooney, & Walter Ling
12. Cocaine, Evaristo Akerele & Niru Nahar
13. Sedatives/Hypnotics and Benzodiazepines, Robert L. DuPont, William M. Greene, & Caroline M. DuPont
IV. Special Populations
14. Polysubstance Use, Abuse, and Dependence, Richard N. Rosenthal, Petros Levounis, & Abigail J. Herron
15. Co-Occurring Substance Use Disorders and Other Psychiatric Disorders, Benjamin C. Silverman, Lisa M. Najavits, Roger D. Weiss
16. Pathological Gambling and Other "Behavioral" Addictions, Liana R. N. Schreiber, Marc N. Potenza, & Jon E. Grant
17. Substance Abuse in Minority Populations, John Franklin
18. Addiction in the Workplace, Laurence Westreich
19. Forensic Approaches to Substances of Abuse, Avram H. Mack
20. Patients with Chronic Pain and Opioid Misuse, Deborah L. Haller & Sidney H. Schnoll
21. Older Adults and Substance Use, Steve Koh, Robert Gorney, Nicolas Badre, & Dilip Jeste 22. HIV/AIDS and Substance Use Disorders, Cheryl Ann Kennedy & Steven J. Schleifer
23. Women and Substance Abuse, Dawn E. Sugarman, Christina Brezing, & Shelly F. Greenfield
24. Substance Use Disorders in Adolescence, Oscar G. Bukstein & Yifrah Kaminer
V. Treatments for Addictions
25. Matching and Differential Therapies: Providing Substance Abusers with Appropriate Treatment, Kathleen M. Carroll & Brian D. Kiluk
26. Individual Psychodynamic Psychotherapy, Lance M. Dodes & Edward J. Khantzian
27. Cognitive Therapy, Judith S. Beck, Bruce S. Liese, & Lisa M. Najavits
28. Group Therapy, Self-Help Groups, and Network Therapy, Marc Galanter
29. Family Therapy Approaches to Substance Use, Edward Kaufman
30. Motivational Interviewing in Psychiatry with Substance Abusing Clients, Jennifer L. Smith, Kenneth M. Carpenter, R. Morgan Wain, & Edward V. Nunes
31. Dialectical Behavior Therapy for Individuals with Borderline Personality Disorder and Substance Use Disorders, Dorian Hunter, M. Zachary Rosenthal, Thomas R. Lynch, and Marsha M. Linehan
32. Psychopharmacological Treatments, Larissa J. Mooney & Elinore F. McCance-Katz
Index